Public disclosures

Leong Justin

Company insiders · Chief Product Officer · RESMED INC

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-20.Following & alerts
Reported transaction lines
1
Buy lines
0
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Leong Justin

Chief Product Officer · RESMED INC

RMD

RESMED INC

Equity grant or award
Filing details

SEC transaction code A

ResMed Common Stock · Direct ownership · Reported balance after transaction: 10314 · Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on November 19, 2026, when the compensation and leadership development committee certified that the performance metrics were met for this portion of the grant.

2026-11-192026-11-20

10,314 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement